Abstinence in patients with alcoholic liver cirrhosis: A follow-up study

Hepatology Research

Volumn 38, Issue 9, 2008, Pages 869-876

  Kalaitzakis, Evangelos ^a   Wallskog, Jesper ^a   Björnsson, Einar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alcohol; Liver cirrhosis; Mortality

Indexed keywords

ACAMPROSATE; ALIMEMAZINE; BENZODIAZEPINE; CARBAMAZEPINE; CARISOPRODOL; CLOMETHIAZOLE; HYDROXYZINE; MELPERONE; MIRTAZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; DEPRESSION; DETOXIFICATION; DISEASE SEVERITY; EATING DISORDER; FEMALE; FOLLOW UP; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; SCORING SYSTEM; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE;

EID: 48949095675     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00353.x     Document Type: Article

References (40)

1. Burra P, Lucey MR. Liver transplantation in alcoholic patients. Transpl Int 2005; 18: 491-8.
2. Lucey MR. Liver transplantation for alcoholic liver disease: Past, present, and future. Liver Transpl 2007; 13: 190-2.
3. Veldt BJ, LainéF, Guillygomarc'h A et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: Quantitative evaluation and optimal timing. J Hepatol 2002; 36: 93-8.
4. Marshall EJ, Alam F. Psychiatric problems associated with alcohol misuse and dependence. Br J Hosp Med 1997; 58: 44-6.
5. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988; 49: 219-24.
6. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 1994; 151: 1723-34.
7. Ewusi-Mensah I, Saunders JB, Williams R. The clinical nature and detection of psychiatric disorders in patients with alcoholic liver disease. Alcohol Alcohol 1984; 19: 297-302.
8. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch Gen Psychiatry 1983; 40: 620-5.
9. Yates WR, Booth BM, Reed DA, Brown K, Masterson BJ. Descriptive and predictive validity of a high-risk alcoholism relapse model. J Stud Alcohol 1993; 54: 645-51.
10. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991; 86: 210-16.
11. McCormick PA, Morgan MY, Phillips A, Yin TP, McIntyre N, Burroughs AK. The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage. J Hepatol 1992; 14: 99-103.
12. Pessione F, Ramond MJ, Peters L et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003; 23: 45-53.
13. Powell WJ Jr, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 1968; 44: 406-20.
14. Borowsky SA, Strome S, Lott E. Continued heavy drinking and survival in alcoholic cirrhotics. Gastroenterology 1981; 80: 1405-9.
15. Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 1981; 282: 263-6.
16. Bell H, Jahnsen J, Kittang E, Raknerud N, Sandvik L. Long-term prognosis of patients with alcoholic liver cirrhosis: A 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol 2004; 39: 858-63.
17. Pande NV, Resnick RH, Yee W, Eckardt VF, Shurberg JL. Cirrhotic portal hypertension: Morbidity of continued alcoholism. Gastroenterology 1978; 74: 64-9.
18. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
19. Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995; 15: 101-9.
20. Conn HO, Bircher J. Hepatic Encephalopathy: Syndromes and Therapies. Bloomington, IL: Medi-Ed Press, 1994.
21. Vaillant GE. A 60-year follow-up of alcoholic men. Addiction 2003; 98: 1043-51.
22. Vaillant GE. The natural history of alcoholism and its relationship to liver transplantation. Liver Transpl Surg 1997; 3: 304-10.
23. Saunders JB, Wodak AD, Williams R. Past experience of advice and treatment for drinking problems of patients with alcoholic liver disease. Br J Addict 1985; 80: 51-6.
24. DiMartini A, Javed L, Russell S et al. Tobacco use following liver transplantation for alcoholic liver disease: An underestimated problem. Liver Transpl 2005; 11: 679-83.
25. DiMartini A, Day N, Dew MA et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 2006; 12: 813-20.
26. Bjornsson E, Olsson J, Rydell A et al. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand J Gastroenterol 2005; 40: 206-16.
27. Wiesner R, Edwards E, Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6.
28. Cholongitas E, Senzolo M, Patch D et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 2006; 23: 883-93.
29. Srikureja W, Kyulo NL, Runyon BA, Hu KQ. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005; 42: 700-6.
30. Bouchier IA, Hislop WS, Prescott RJ. A prospective study of alcoholic liver disease and mortality. J Hepatol 1992; 16: 290-7.
31. Brunt PW, Kew MC, Scheuer PJ, Sherlock S. Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut 1974; 15: 52-8.
32. Kamper-Jorgensen M, Gronbaek M, Tolstrup J, Becker U. Alcohol and cirrhosis: Dose - response or threshold effect? J Hepatol 2004; 41: 25-30.
33. Pares A, Barrera JM, Caballeria J et al. Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology 1990; 12: 1295-9.
34. Mendenhall CL, Seeff L, Diehl AM et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119). Hepatology 1991; 14: 581-9.
35. Shiomi S, Kuroki T, Minamitani S et al. Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol 1992; 7: 274-6.
36. Takase S, Tsutsumi M, Kawahara H, Takada N, Takada A. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 1993; 17: 9-13.
37. Kubo S, Kinoshita H, Hirohashi K et al. High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus. Surgery 1997; 121: 425-9.
38. Kwon SY, Ahn MS, Chang HJ. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea. J Gastroenterol Hepatol 2000; 15: 1282-6.
39. Yamanaka T, Shiraki K, Nakazaawa S et al. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Anticancer Res 2001; 21: 2937-40.
40. DiMartini A, Day N, Dew MA et al. Alcohol use following liver transplantation: A comparison of follow-up methods. Psychosomatics 2001; 42: 55-62.